Home › Overweight › California › Indio
Overweight clinical trials in Indio, CA
5 studies for Overweight are looking for participants at sites in and around Indio (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
RecruitingPhase 3
- Desert Oasis Healthcare Medical Group, Palm Springs · 20 mi away
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
RecruitingPhase 3
- Desert Oasis Healthcare, Palm Springs · 20 mi away
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
RecruitingPhase 3
- Desert Oasis Healthcare Medical Group, Palm Springs · 20 mi away
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
RecruitingPhase 3
- Desert Oasis Healthcare Medical Group, Palm Springs · 20 mi away
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
RecruitingPhase 3
- Desert Oasis Healthcare, Palm Springs · 20 mi away
Overweight trials in other cities
- Houston, TX33 studies
- San Antonio, TX33 studies
- Chicago, IL28 studies
- Orlando, FL25 studies
- Las Vegas, NV23 studies
- Miami, FL23 studies
- Dallas, TX20 studies
- Atlanta, GA20 studies
- Washington, DC19 studies
- Jacksonville, FL19 studies
- New York City, NY19 studies
- Austin, TX18 studies
Other studies in Indio
- Breast Cancer6 studies
- Obesity5 studies
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy5 studies
- Knee Osteoarthritis4 studies
- Prostate Cancer3 studies
- Non-Small Cell Lung Cancer3 studies
- Lung Cancer3 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.